Position
Marex Group plc in Cvs Health Corp
Back to the book · All holders of CVS
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark −$323.2K$62.88 → $44.89
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q2 2023 | 13.6K | $938.9K | — | — | — | 0.2% |
| Q3 2023 | 31K | $2.17M | $69.82 | $9.37K | $1.22M | 0.3% |
| Q4 2023 | 90.4K | $7.14M | $78.96 | $283.5K | $4.69M | 0.3% |
| Q1 2024 | 79K | $6.3M | $79.76 | $63.2K | −$899.2K | 0.2% |
| Q2 2024 | 27.3K | $1.61M | $59.06 | −$564.8K | −$4.12M | 0.0% |
| Q3 2024 | 18K | $1.13M | $62.88 | $68.6K | −$550.3K | 0.0% |
| Q4 2024 | 36.6K | $1.64M | $44.89 | −$323.2K | $834.6K | 0.0% |